Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2008
09/24/2008CN101273028A Macrocyclic inhibitors of hepatitis C virus
09/24/2008CN101273027A Macrocyclic inhibitors of hepatitis C virus
09/24/2008CN101273021A Selected CGRP antagonists, methods for the production thereof and their use as medicaments
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427628 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
09/23/2008US7427626 useful in Pharmaceutical medicines or pharmacological tools; cytostatic agents; antiproliferative/antineoplastic agents; 2-Anilino-4-[1-isopropyl-2-(hydroxyiminomethyl)imidazol-5-yl]pyrimidine; rheumatoid arthritis; breast cancer
09/23/2008US7427620 4-{4-[4-{4-[2-(2-pyridinyl)-2-(1 H-1,2,4-triazol- 1 -yl-methyl)- 1 ,3-dioxolan-4-yl-methoxy]phenyl}- 1-piperazinyl]-phenyl}-2-( 1-methyl)-propyl-2,4-dihydro-3H-1,2,4-triazol-3-one; better toxicological profile and of reduced interaction with other drugs; good solubility in water, bioavailability
09/23/2008US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine
09/23/2008US7427608 Protection against and treatment of hearing loss
09/23/2008CA2480800C Inhibitors of akt activity
09/23/2008CA2450093C Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2416169C Compositions containing therapeutically active components having enhanced solubility
09/23/2008CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors
09/23/2008CA2354852C 4,5-azolo-oxindoles
09/18/2008WO2008112913A1 Inhibitors of the hedgehog pathway
09/18/2008WO2008112642A1 Aminopyrimidines useful as inhibitors of protein kinases
09/18/2008WO2008112479A1 Salts of 3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl] -pyrrole-2, 5-di one
09/18/2008WO2008112408A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008WO2008112407A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008WO2008111604A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
09/18/2008WO2008111077A2 Self-assembled polyhedral multimeric chemical structures
09/18/2008WO2008110611A1 Organic compounds and their uses
09/18/2008WO2008110566A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/18/2008WO2008110196A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
09/18/2008WO2008110062A1 Compounds with partial agonist activity of pparϝ and application thereof
09/18/2008WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008WO2008087278A3 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
09/18/2008WO2008063232B1 Substituted pyrazolopyrimidines
09/18/2008US20080227981 Charge transport compositions and electronic devices made with such compositions
09/18/2008US20080227842 Non-fluorescent chlorophyll catabolites
09/18/2008US20080227839 Kinase Inhibitors
09/18/2008US20080227837 Novel Compounds
09/18/2008US20080227794 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
09/18/2008US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement
09/18/2008US20080227792 3,4-Dihydro-1H-Isoquinoline-2-Carboxylic Acid 5-Aminopyridin-2-Yl Esters
09/18/2008US20080227790 treating an airway disorder; 4-(3-{3,4-dimethoxyphenyl}-5,5-dimethyl-6-oxo-5,6-dihydro-4H-pyridazin-1-yl)-benzoic acid
09/18/2008US20080227789 5-(quinoxalin-2-yl)-N2-(3,4,5-trimethoxyphenyl)thiazole-2,4-diamine; useful in inhibiting the activity of the receptor protein tyrosine kinase Axl; rheumatoid arthritis, vascular disease, vascular injury, psoriasis, visual impairment due to macular degeneration, diabetic retinopathy, retinopathy
09/18/2008US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride
09/18/2008US20080227782 Pyrimidine amide compounds as pgds inhibitors
09/18/2008US20080227781 Imidazole compounds for the treatment of neurodegenerative disorders
09/18/2008US20080226622 Hypoxia inducible factor (Hif); for modulating mRNA translation within cells; prevents excessive vascularization
09/18/2008DE102007012284A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments
09/18/2008CA2709220A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008CA2681162A1 Benzyl and pyridine derivatives as modulators of hedgehog pathway
09/18/2008CA2681005A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008CA2680796A1 Inhibitors of the hedgehog pathway
09/18/2008CA2679884A1 Aminopyrimidines useful as inhibitors of protein kinases
09/18/2008CA2679866A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
09/17/2008EP1970375A1 Arylmethylene urea derivative and use thereof
09/17/2008EP1970373A1 Alicyclic heterocyclic compound
09/17/2008EP1968969A2 Organic compounds
09/17/2008EP1968967A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
09/17/2008EP1968962A2 Diaza heterocyclic sulfonamide derivatives and their uses
09/17/2008EP1968947A1 Gaba-b receptor modulators
09/17/2008EP1968579A1 Pharmaceutical compounds
09/17/2008EP1732892B1 Tetrahydrocarbazoles and derivatives
09/17/2008EP1325910B1 Aliphatic nitrogenous five-membered ring compounds
09/17/2008EP1272827B1 Analyte detection
09/17/2008CN101268070A Novel sulphonylpyrroles as inhibitors of HDAC novel sulphonylpyrroles
09/17/2008CN101268067A Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as V1A receptor antagonists
09/17/2008CN101268066A A process for the preparation of sartan derivatives and intermediates useful in such process
09/17/2008CN101268065A Process for preparing an angiotensin II receptor antagonist
09/17/2008CN101268064A Pyrazine derivatives useful as adenosine receptor antagonists
09/17/2008CN101268059A 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides
09/17/2008CN101268058A 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
09/17/2008CN101265259A Novel IDO inhibitor and its usage method
09/17/2008CN101265254A Novel IDO inhibitor and its usage method
09/17/2008CN100418962C Technique for synthesizing Irbesartan
09/17/2008CN100418955C Novel Benzo-fused heterocycles
09/17/2008CN100418953C Process for manufacture of telmisartan
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/17/2008CN100418948C Hydroxypyridine cgrp receptor antagonists
09/16/2008US7425638 Cis-imidazolines
09/16/2008US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent
09/16/2008US7425633 (3S,5S)-5-(pyrrolidine-1-carbonyl)-N-((1S,2R)-2-(3-(trifluoromethyl)phenyl)cyclopropyl)pyrrolidine-3-carboxamide; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
09/16/2008US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
09/16/2008US7425557 Inhibitors of glycogen synthase kinase 3
09/16/2008US7425553 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
09/16/2008US7425550 Lactam glycogen phosphorylase inhibitors and method of use
09/16/2008US7425451 Sequestering proteins, peptides; determination concentration in mixture; analyzing by mass spectroscopy
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/16/2008CA2427221C Process and intermediates for preparing anti-cancer compounds
09/16/2008CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
09/12/2008WO2008109700A1 Ppar active compounds
09/12/2008WO2008109467A1 Electrically conducting porphyrin and porphyrin-fullerene electropolymers
09/12/2008WO2008109333A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor
09/12/2008WO2008109314A1 Heterocyclic compounds, compositions comprising them and methods of their use
09/12/2008WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109056A1 Sulfonylated heterocycles useful for modulation of the progesterone receptor
09/12/2008WO2008108729A1 Novel 2-heteroaryl substituted indoles 695
09/12/2008WO2008108486A1 1-biarylazetidinone derivatives
09/12/2008WO2008107799A2 Improved process for preparing irbesartan
09/12/2008WO2008107436A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
09/12/2008WO2008107398A2 Pyrazine compounds
09/12/2008WO2008107322A1 Indole, benzimidazole or benzotriazole derivatives including a piperidine or piperazine core as anti-neoplasic agents or cell proliferation inhibitors
09/12/2008WO2008076245A3 Nitroderivatives as angiotensin ii receptor antagonists
09/12/2008WO2008073461A3 Ion channel modulators
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 626